References
- Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16.
- Colson P, Rolain J-M, Lagier J-C, et al. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55(4):105932.
- Hinton DM. Food and Drug Administration. FDA Emergency use authorization (EUA) of chloroquine and hydroxychloroquine. 28 Mar 2020. Available from: https://www.fda.gov/media/136534/download
- Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(9):1036–1041.
- Yanturali S, Aksay E, Demir OF, et al. Massive hydroxychloroquine overdose. Acta Anaesthesiol Scand. 2004;48(3):379–381.
- Isbister GK, Dawson A, Whyte IM. Hydroxychloroquine overdose: a prospective case series. Am J Emerg Med. 2002;20(4):377–378.
- Marquardt K, Albertson TE. Treatment of hydroxychloroquine overdose. Am J Emerg Med. 2001;19(5):420–424.
- Mégarbane B, Bloch V, Hirt D, et al. Blood concentrations are better predictors of chloroquine poisoning severity than plasma concentrations: a prospective study with modelling of the concentration/effect relationships. Clin Toxicol. 2010;48(9):904–915.
- Riou B, Barriot P, Rimailho A, et al. Treatment of severe chloroquine poisoning. N Engl J Med. 1988;318(1):1–6.
- Ten Broeke R, Mestrom E, Woo L, et al. Early treatment with intravenous lipid emulsion in potentialy lethal hydroxychloroquine intoxication. Neth J Med. 2016;74(5):210–214.
- Mongenot F, Tessier Gonthier Y, Derderian F, et al. Treatment of hydroxychloroquine poisoning with extracorporeal circulation. Ann Fr Anesth Reanim. 2007;26(2):164–167.
- Weiner L, Mazzeffi MA, Hines EQ, et al. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the extracorporeal life support organizations' ECMO case registry. Clin Toxicol (Pila). 2020;58(7):705–710.
- Masson R, Colas V, Parienti JJ, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012;83(11):1413–1417.
- Pozzi M, Koffel C, Djaref C, et al. High rate of arterial complications in patients supported with extracorporeal life support for drug intoxication-induced refractory cardiogenic shock or cardiac arrest. J Thorac Dis. 2017;9(7):1988–1996.